MYRIAD GENETICS, INC. Receivable with Imputed Interest, Effective Yield (Interest Rate)
MYRIAD GENETICS, INC. (MYGN) reported Receivable with Imputed Interest, Effective Yield (Interest Rate) of 6.00% for the 12-month period ending 2014-06-30, per its 10-K filed 2014-08-13.
Discontinued › Notes › and Others › Receivables with Imputed Interest
us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate · last filed 2014-08-13
- MYRIAD GENETICS, INC. receivable with imputed interest, effective yield (interest rate) for fiscal 2014 was 6.00%.
| Period end | Receivable with Imputed Interest, Effective Yield (Interest Rate) 1 month | Receivable with Imputed Interest, Effective Yield (Interest Rate) 6 month | Receivable with Imputed Interest, Effective Yield (Interest Rate) 9 month | Receivable with Imputed Interest, Effective Yield (Interest Rate) 12 month |
|---|---|---|---|---|
| 2014-06-30 | 6.00% 10-K · filed 2014-08-13 | |||
| 2013-12-31 | 7.00% 10-Q · filed 2014-02-05 | |||
| 2013-09-30 | 7.00% 10-Q · filed 2013-11-12 | |||
| 2012-09-30 | 7.00% 10-K · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |